Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 10, 2014 - Issue 7
Submit an article Journal homepage
1,808
Views
16
CrossRef citations to date
0
Altmetric
Review

Fast vaccine design and development based on correlates of protection (COPs): Influenza as a trendsetter

Cécile van Els National Institute for Public Health and the Environment; Bilthoven, the Netherlands
,
Siri Mjaaland Norwegian Institute of Public Health; Oslo, Norway
,
Lisbeth Næss Norwegian Institute of Public Health; Oslo, Norway
,
Julia Sarkadi National Center for Epidemiology (NCE); Budapest, Hungary
,
Eva Gonczol National Center for Epidemiology (NCE); Budapest, Hungary
,
Karen Smith Korsholm Statens Serum Institut; Copenhagen, Denmark
,
Jon Hansen Statens Serum Institut; Copenhagen, Denmark
,
Jørgen de Jonge National Institute for Public Health and the Environment; Bilthoven, the Netherlands
,
Gideon Kersten Institute for Translational Vaccinology; Bilthoven, the Netherlands; Leiden Academic Center for Drug Research; University of Leiden; The Netherlands
,
Jennifer Warner Public Health England; Porton Down, England
,
Amanda Semper Public Health England; Porton Down, England
,
Corine Kruiswijk Institute for Translational Vaccinology; Bilthoven, the Netherlands
&
Fredrik Oftung Norwegian Institute of Public Health; Oslo, NorwayCorrespondence[email protected]
 show all
Pages 1935-1948 | Received 05 Dec 2013, Accepted 24 Mar 2014, Published online: 24 Apr 2014

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Stefan H.E. Kaufmann, January Weiner$suffix/text()$suffix/text() & Jeroen Maertzdorf. (2017) Accelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers. Expert Review of Vaccines 16:8, pages 845-853.
Read now
Claudia Maria Trombetta & Emanuele Montomoli. (2016) Influenza immunology evaluation and correlates of protection: a focus on vaccines. Expert Review of Vaccines 15:8, pages 967-976.
Read now
Renée A J van Boxtel, Pauline Verdijk, Otto J de Boer, Elly van Riet, Tjeert T Mensinga & Willem Luytjes. (2015) Safety and immunogenicity of influenza whole inactivated virus vaccines: A phase I randomized clinical trial. Human Vaccines & Immunotherapeutics 11:4, pages 983-990.
Read now

Articles from other publishers (13)

Fredrik Oftung, Lisbeth M. Næss, Ida Laake, Gregory Stoloff & Olga Pleguezuelos. (2022) FLU-v, a Broad-Spectrum Influenza Vaccine, Induces Cross-Reactive Cellular Immune Responses in Humans Measured by Dual IFN-γ and Granzyme B ELISpot Assay. Vaccines 10:9, pages 1528.
Crossref
Paolo Bonanni, Rafael Cantón, Dipender Gill, Philippe Halfon, Uwe G. Liebert, Katya A. Nogales Crespo, Jaime J. Pérez Martín & Claudia M. Trombetta. (2021) The Role of Serology Testing to Strengthen Vaccination Initiatives and Policies for COVID-19 in Europe. COVID 1:1, pages 20-38.
Crossref
Xunyan Ye, Obinna P. Iwuchukwu, Vasanthi Avadhanula, Letisha O. Aideyan, Trevor J. McBride, David M. Henke, Kirtida D. Patel, Felipe-Andres Piedra, Laura S. Angelo, Dimpy P. Shah, Roy F. Chemaly & Pedro A. Piedra. (2021) Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients. Viruses 13:6, pages 991.
Crossref
Pengfei Jin, Jingxin Li, Hongxing Pan, Yanfei Wu & Fengcai Zhu. (2021) Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need. Signal Transduction and Targeted Therapy 6:1.
Crossref
Wey Wen Lim, Nancy H L Leung, Sheena G Sullivan, Eric J Tchetgen Tchetgen & Benjamin J Cowling. (2020) Distinguishing Causation from Correlation in the Use of Correlates of Protection to Evaluate and Develop Influenza Vaccines. American Journal of Epidemiology 189:3, pages 185-192.
Crossref
Yasaman Mortazavi, Salum J. Lidenge, Tara Tran, John T. West, Charles Wood & For Yue Tso. (2020) The Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) gH/gL Complex Is the Predominant Neutralizing Antigenic Determinant in KSHV-Infected Individuals. Viruses 12:3, pages 256.
Crossref
Stanley A. Plotkin. (2020) Updates on immunologic correlates of vaccine-induced protection. Vaccine 38:9, pages 2250-2257.
Crossref
Nirianne Marie Q. Palacpac & Toshihiro Horii. (2020) Malaria vaccines: facing unknowns. F1000Research 9, pages 296.
Crossref
Gregg N. Milligan, Barbara S. Schnierle, Alexander J. McAuley & David W.C. Beasley. (2019) Defining a correlate of protection for chikungunya virus vaccines. Vaccine 37:50, pages 7427-7436.
Crossref
Hao Li & Babak Javid. (2018) Antibodies and tuberculosis: finally coming of age?. Nature Reviews Immunology 18:9, pages 591-596.
Crossref
Gulbanu Sarsenbayeva, Yevgeniy Volgin, Markhabat Kassenov, Timur Issagulov, Nikolay Bogdanov, Abylay Sansyzbay, Ruslan Abitay, Ainur Nurpeisova, Altynay Sagymbay, Zhumagali Koshemetov, Marina Stukova, Zhanna Buzitskaya, Ilyas Кulmagambetov, Dinara Karabayeva, Timur Davlyatshin & Berik Khairullin. (2018) Safety and immunogenicity of the novel seasonal preservative- and adjuvant-free influenza vaccine: Blind, randomized, and placebo-controlled trial. Journal of Medical Virology 90:1, pages 41-49.
Crossref
Peter C. Soema, Ronald Kompier, Jean-Pierre Amorij & Gideon F.A. Kersten. (2015) Current and next generation influenza vaccines: Formulation and production strategies. European Journal of Pharmaceutics and Biopharmaceutics 94, pages 251-263.
Crossref
Peter Christiaan Soema, Elly van Riet, Gideon Kersten & Jean-Pierre Amorij. (2015) Development of Cross-Protective Influenza A Vaccines Based on Cellular Responses. Frontiers in Immunology 6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.